PCM Encore LLC Takes $620,000 Position in CVS Health Corporation $CVS

PCM Encore LLC purchased a new stake in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 5,997 shares of the pharmacy operator’s stock, valued at approximately $620,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of CVS Health during the 2nd quarter worth approximately $12,747,462,000. Norges Bank bought a new position in shares of CVS Health in the 4th quarter worth approximately $1,666,265,000. Wellington Management Group LLP lifted its stake in shares of CVS Health by 193.2% in the 4th quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after purchasing an additional 12,233,675 shares during the period. Pzena Investment Management LLC bought a new stake in shares of CVS Health during the second quarter valued at approximately $1,217,558,000. Finally, Bank of New York Mellon Corp purchased a new stake in CVS Health in the second quarter worth $932,454,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Price Performance

CVS opened at $93.83 on Friday. The firm has a market cap of $120.01 billion, a PE ratio of 24.82, a P/E/G ratio of 0.89 and a beta of 0.61. The stock has a 50-day moving average price of $102.19 and a 200-day moving average price of $88.83. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is 70.37%.

Analysts Set New Price Targets

CVS has been the subject of a number of research reports. Piper Sandler reiterated an “overweight” rating and issued a $113.00 price objective on shares of CVS Health in a report on Monday, June 1st. Sanford C. Bernstein upped their target price on shares of CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 12th. Mizuho increased their price target on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Truist Financial lifted their price target on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Cantor Fitzgerald upped their price objective on shares of CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a report on Tuesday, July 7th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.